3rd Quarter - Report

THE MCMANUS GROUP for LARGE UROLOGY GROUP PRACTICE ASSOCIATION

Firm
Client
Income
$90,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to access and physician reimbursement under Medicare Part B. Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. H.R. 2484- Seniors' Access to Critical Medications Act of 2025. Issues related to prior authorization. Issues related to physician reimbursement for Part B drugs. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act Issues related to the 2026 Medicare Physician Fee Schedule Proposed Rule (CMS-1832-P).

LobbyistCovered position, as disclosed
LAWREN D GEER —
JOHN MCMANUS —
ALEX WHALEN —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 4299 (119th), H.R. 2484 (119th)

Health Issues HCR

Issues related to reforming and increasing transparency within the 340B Drug Pricing Program.

LobbyistCovered position, as disclosed
LAWREN D GEER —
JOHN MCMANUS —
ALEX WHALEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.